Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease-Associated Parkinsonism: Insights Into a Potential Therapeutic Target. [PDF]
Ardizzone A +8 more
europepmc +1 more source
Exploring delayed diagnosis in Gaucher disease: insights from a community survey and potential solutions. [PDF]
Aragón DPP +6 more
europepmc +1 more source
The c-Abl-RIPK3 Axis Drives Mitochondrial Dysfunction and Impaired Mitophagy in Gaucher Disease Models. [PDF]
Lamaizon CM +8 more
europepmc +1 more source
Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype. [PDF]
Cullufi P +8 more
europepmc +1 more source
Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease. [PDF]
Fang Z +5 more
europepmc +1 more source
Longitudinal Evaluation of Neurological and Sensory Changes in Gaucher Disease: A Prospective Observational Cohort Study (SENOPRO). [PDF]
Cerulli Irelli E +14 more
europepmc +1 more source
Diagnosis and follow-up of the first case of Gaucher disease under enzyme replacement therapy in Senegal. [PDF]
Keita M +7 more
europepmc +1 more source
Unveiling an Uncommon Glucosylceramidase (GBA) Mutation: Gaucher Disease Due to p.Ser276Phe Substitution. [PDF]
Kumar N +4 more
europepmc +1 more source
Repurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.
Minea C, Deegan PB.
europepmc +1 more source

